Breast cancer therapeutics market – DataM Intelligence
Breast cancer therapeutics market size reached US$ 37.75 Billion in 2024 and is expected to reach US$ 72.05 Billion by 2033, growing at a CAGR of 9.4% during the forecast period 2025-2033
DataM Intelligence has published a new research report on “Breast Cancer Therapeutics Market Size 2025”. The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/breast-cancer-therapeutics-market?sg
Key Players: Genentech USA, Inc., Pfizer Inc., Novartis Pharmaceuticals Inc., AstraZeneca, Eli Lilly Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., and GSK
Industry Latest News 2025
✅ 13 Jan 2025 – Eli Lilly to acquire Scorpion Therapeutics (STX-478 PI3Kα program) – up to $2.5B (upfront + milestones). Transaction buys a PI3Kα programme that’s being developed for breast cancer and other solid tumours; Scorpion will spin out non-PI3K assets.
✅ 17 Jan 2025 – FDA approves DATROWAY® (datopotamab deruxtecan) for unresectable/metastatic HR-positive, HER2-negative breast cancer after endocrine-based therapy + chemotherapy. (TROP-2 directed ADC; expands ADC options in HR+/HER2- disease).
✅ 27 Jan 2025 – FDA approves ENHERTU® (fam-trastuzumab deruxtecan-nxki) for unresectable/metastatic HR-positive, HER2-low and HER2-ultralow breast cancer after progression on endocrine therapy. (Approval based on DESTINY program data; includes companion diagnostic).
✅ 04 Apr 2025 – European Commission / EMA grants marketing authorisation for DATROWAY® (datopotamab deruxtecan) in the EU for previously-treated HR+/HER2- breast cancer. (EU product information / EPAR published).
✅ 21 Mar 2025 – AstraZeneca enters a global strategic collaboration with Harbour BioMed (multi-billion milestone potential) to discover/develop next-generation therapeutic antibodies (oncology focus). (Large partnership that furthers antibody and multi-specific programmes relevant to oncology drug discovery including breast cancer targets).
✅ June 2025 (ASCO / scientific meeting coverage) – Multiple breast-cancer trial readouts and combination data presented (ADCs, HER2-low strategies, endocrine+targeted combos), shaping near-term label/launch and trial strategies.
Growth Forecast Projected:
The Global Breast Cancer Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Breast Cancer Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=breast-cancer-therapeutics-market?sg
Key Segments:
By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery),
By Routes of Administration (Intravenous, Oral Route, Subcutaneous (SC) Route, Other Routes)
By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies)
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report’s coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Breast Cancer Therapeutics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market’s key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Breast Cancer Therapeutics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry’s supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report’s key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/breast-cancer-therapeutics-market?sg
FAQ’s
Q1: What is the current size of the Breast Cancer Therapeutics Market?
A: The Breast Cancer Therapeutics Market stood at US$ 37.75 Billion in 2024 and is set to experience remarkable growth, reaching US$ 72.05 Billion by 2033
Q2: How fast is the Breast Cancer Therapeutics Market growing?
A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 9.4% from 2025-2033
Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/breast-cancer-therapeutics-market?sg
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us –
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us –
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.